Cure My Disease

Don't miss your cure!

 Log in / Sign up

New needling method could ease stubborn back pain

NCT ID NCT07345871

Symptom relief Sponsor: University of Social Welfare and Rehabilitation Science Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a special dry needling technique, called connective tissue dry needling, can help people with long-term low back pain caused by a specific spot near the hip bone. About 42 adults will either get the needling plus exercises, or just exercises, for two weeks. Researchers will measure pain, movement, and quality of life to see if the needling adds extra benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 42 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: 1. Adults aged 18 to 75 years. 2. Diagnosed with chronic mechanical low back pain localized at the posterior superior iliac spine region. 3. Presence of point tenderness reproducible by palpation at the posterior superior iliac spine area. 4. Pain duration of at least two weeks, indicating the non-acute stage of low back pain. 5. Negative results in at least three out of five sacroiliac pain provocation tests (Distraction, Compression, Thigh Thrust, Sacral Thrust, Gaenslen). 6. Pain intensity ≥ 3 on the Numeric Rating Scale at baseline. 7. Ability to communicate and cooperate with the research team during intervention and follow-up. 8. Access to WhatsApp or equivalent communication application for follow-up pain reporting at the 3-month stage. Non-inclusion criteria: 1. Presence of lumbar radicular pain or referred pain to the lower limbs. 2. History of lumbar spine trauma within the previous three months. 3. Fear or intolerance of needling procedures. 4. Current use of anticoagulant medication. 5. Known lymphatic disorders, immunosuppressive diseases, or neurological conditions such as epilepsy or seizure disorders. 6. Pregnancy or suspected pregnancy. Exclusion criteria: 1. Voluntary withdrawal of consent at any time during the study. 2. Inability to tolerate the intervention or adverse reaction during treatment sessions. 3. Occurrence of serious adverse events or complications (e.g., infection, bleeding). 4. Non-compliance with treatment protocol or missing more than two sessions. 5. Any intercurrent illness or therapy that could interfere with the study outcomes or safety assessment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic low back pain (CLBP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

connective tissue disorder Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic low back pain (CLBP) Mechanical low back pain Sacroiliac joint dysfunction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.